[DNA repair and repair diseases: between molecular models and clinical reality].
Nicolas Foray, Pierre Verrelle
https://pubmed.ncbi.nlm.nih.gov/21454154/Actively Recruiting
Led by Association Francaise pour la Recherche Thermale · Updated on 2026-04-13
110
Participants Needed
13
Research Sites
52 weeks
Total Duration
Researchers are evaluating the medical benefit of spa therapy on skin and soft tissue fibrosis that occurs as a late reaction at least 6 months after radiotherapy for breast cancer or Upper Aerodigestive Tract UADT cancer. This randomized, controlled, multicenter trial aims to assess improvements in quality of life related to dermatological sequelae of fibrosis. The study focuses on patients with severe late reactions and compares immediate versus delayed spa treatment. The intervention being studied is a dermatologically oriented thermal cure that includes sedative and muscle-relaxing baths, decongestant sprays, and high-pressure thread-like showers using thermal water. Educational workshops on relaxation, sophrology, and hygiene are also part of the therapy. Participants are randomly assigned to receive spa treatment either immediately within 6 weeks of inclusion or after a 6-month delay, allowing comparison of outcomes between early and late treatment groups. Participants will be involved for at least 6 months, during which they will self-assess their dermatological quality of life using the DLQI score and undergo evaluations of generic and cancer-specific quality of life. Additional assessments include self-reported sequelae, radiological examinations of lesions, thickness, and volume, as well as monitoring of treatment and medical consultations. Adverse events and long-term quality of life benefits up to 12 months will be recorded to understand the therapys impact and safety.
CONDITIONS
Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer
N
Nans FUSTIER
C
Claire Eychenne
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Association Francaise pour la Recherche Thermale
Lead Sponsor
Floralis
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 weeks after inclusion
Participants receive a dermatologically oriented spa therapy involving baths, sprays, and high-pressure thermal water showers, along with educational workshops to improve dermatological quality of life.
1 treatment period within 6 weeks after inclusion
Duration - After the 6-month visit
Participants in the control group receive the same spa therapy after a delay of 6 months following the initial inclusion visit.
1 treatment period starting after 6 months
Duration - Up to 12 months
Participants are assessed for quality of life, lesion and fibrosis characteristics, treatment consumption, and adverse events up to 12 months after treatment.
Visits at 6 and 12 months after treatment
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Nicolas Foray, Pierre Verrelle
https://pubmed.ncbi.nlm.nih.gov/21454154/Rebecca K S Wong, René-Jean Bensadoun, Christine B Boers-Doets...
https://pubmed.ncbi.nlm.nih.gov/23942595/Sylvie Delanian, Jean-Louis Lefaix
https://pubmed.ncbi.nlm.nih.gov/17395040/Bidhu K Mohanti, Manishi Bansal
https://pubmed.ncbi.nlm.nih.gov/16041503/N G Burnet, J Johansen, I Turesson...
https://pubmed.ncbi.nlm.nih.gov/9842969/F Kwiatkowski, M A Mouret-Reynier, M Duclos...
https://pubmed.ncbi.nlm.nih.gov/23352440/S Johansson, H Svensson, J Denekamp
https://pubmed.ncbi.nlm.nih.gov/11020571/Catherine L Ly, Sumun Khetpal, Danielle R Heller...
https://pubmed.ncbi.nlm.nih.gov/33886127/U M Carl, J J Feldmeier, G Schmitt...
https://pubmed.ncbi.nlm.nih.gov/11240244/P Hardy
https://pubmed.ncbi.nlm.nih.gov/5678765/Association Francaise pour la Recherche Thermale
Lead Sponsor
Floralis
Collaborating Sponsor